These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12478836)

  • 1. [Androgen receptor isoforms in LNCaP cell and human prostate].
    Xia SJ; Tang XD
    Zhonghua Nan Ke Xue; 2002; 8(3):169-72. PubMed ID: 12478836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor isoforms in human prostatic cancer tissue and LNCaP cell line.
    Xia SJ; Tang XD; Ma QZ
    Asian J Androl; 2001 Sep; 3(3):223-5. PubMed ID: 11561194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor isoforms in human and rat prostate.
    Xia SJ; Hao GY; Tang XD
    Asian J Androl; 2000 Dec; 2(4):307-10. PubMed ID: 11202423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of androgen receptor isoforms in normal human prostate].
    Xia SJ; Hao GY; Wen W; Zhang J; Li WG; Zhu YY; Tang XD
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):501-3, 506. PubMed ID: 14628596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Androgen receptor isoforms expression and its novel cDNA cloning in human prostate].
    Xia S; Wang Y; Tang X
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1500-3. PubMed ID: 16200775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human prostate cancer cell to hormone inhibited by androgen receptor antisense RNA.
    Jiang J; Wang LF; Fang YH; Jin FS; Jin WS
    Chin Med J (Engl); 2004 May; 117(5):684-8. PubMed ID: 15161534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG
    Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
    Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R
    Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
    Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
    Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y
    Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.